3 excellent ASX shares to buy for your SMSF

Analysts think these shares could be top picks for SMSF investors. Let's find out why.

| More on:
Two people having a meeting using a laptop and tablet to discuss Seven West Media's balance sheet

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

For Australia's growing community of self-managed super fund (SMSF) trustees, long-term thinking is everything.

With over 625,000 SMSFs holding a collective $990 billion in assets as of 30 June 2024, according to the ATO, more Australians than ever are taking control of their retirement outcomes — and doing so with an eye on quality, sustainability, and growth.

If you're managing your own super, choosing the right ASX shares can make a significant difference to your wealth over time.

The goal? Own companies with durable advantages, strong leadership, and clear growth runways that can compound for years to come.

With that in mind, here are three excellent ASX shares that analysts think could make strong long-term additions to any SMSF portfolio. They are as follows:

Goodman Group (ASX: GMG)

Goodman Group is a standout in the property space. Instead of shopping centres or office towers, it focuses on high-demand industrial assets like warehouses, distribution centres, and data infrastructure.

It is a pure play on the rise of e-commerce, supply chain modernisation, and the cloud economy. Major global names like Amazon and Microsoft are Goodman tenants, and the company has a development pipeline geared towards supporting data centre.

Citi currently rates Goodman as a buy with a $40.00 price target.

ResMed Inc. (ASX: RMD)

Another ASX SMSF share to look at is ResMed. It is a global leader in sleep and respiratory medicine, known for its innovative CPAP machines and digital health solutions. The company's technology helps millions of people around the world manage sleep apnoea and chronic respiratory conditions — and demand is only rising.

For SMSF investors looking to invest in healthcare innovation with global scale and recurring revenue, ResMed ticks all the boxes.

Goldman Sachs rates the company very highly. It has a conviction buy rating and $49.30 price target on its shares.

Xero Ltd (ASX: XRO)

Finally, Xero could be an ASX share to buy for an SMSF. It has grown into one of Australia and New Zealand's biggest tech success stories — and there's still a long road ahead. The company provides cloud-based accounting software to just over 4 million subscribers globally, with deep penetration across ANZ and increasing traction in key international markets.

Xero generates recurring, high-margin revenue, and while it's still investing for growth, the business is now focused on profitability and operating leverage. Its customer base of small and medium businesses is loyal, sticky, and growing — making it a compelling software-as-a-service (SaaS) play for long-term investors.

Goldman Sachs estimates that it has a 100 million total addressable market. This gives it a significant growth runway over the next decade or two.

It is for this reason that Goldman has a buy rating and $201.00 price target on its shares.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Goodman Group, ResMed, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Goodman Group, ResMed, and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a man holds a firework sparkler in both hands as a shower of sparkly confetti falls from the sky around him as he smiles and closes his eyes in a celebratory scene.
Growth Shares

Happy New Year: Here are two ASX stocks to watch going into 2026

Analysts are expecting big things from these shares this year.

Read more »

Two people jump and high five above a city skyline.
Growth Shares

The top ASX growth stocks that could rebound in 2026 after a brutal year

Analysts see potential for these shares to rebound strongly next year.

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Growth Shares

The Australian stocks I'd trust for the next 10 years

It is no surprise that brokers rate these stocks as buys.

Read more »

A smartly-dressed businesswoman walks outside while making a trade on her mobile phone.
Growth Shares

2 stocks to help turn $100,000 into $1 million

You don’t need moonshots to build wealth.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Growth Shares

10 ASX shares I would buy in 2026

I think these are among the best stocks to buy for an ASX share portfolio in the new year.

Read more »

A man points at a paper as he holds an alarm clock, indicating the ex-dividend date is approaching.
Growth Shares

In 2036, you will be glad you bought these ASX shares today

Want to make long term investments? I think these shares could be top picks.

Read more »

fintech, smart investor, happy investor, technology shares,
Growth Shares

These ASX 200 growth shares could be much bigger in 2035

Want to make buy and hold investments? Analysts think these shares could be top picks.

Read more »

A group of businesspeople clapping.
Growth Shares

These could be 3 of the best ASX stocks to own in 2026

Analysts think these shares are best buys for the year ahead. Let's see what they offer.

Read more »